Product

Product

Casimersen

CAS NO.: 1422958-19-7Synonyms: SRP-4045Molecular Formula: C268H424N124O95P22Molecular Weight:7584.536 Application: Casimersen, sold under the brand name Amondys 45, is an antisense oligonucleotide medication used for the treatment of Duchenne muscular dystrophy (DMD) in people who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping. It is an antisense oligonucleotide of phosphorodiamidate …

Casimersen Read More »

Viltolarsen

CAS NO.: 2055732-84-6Synonyms: NCNP-01Molecular Formula: C244H381N113O88P20Molecular Weight:6924.910 Application: Viltolarsen, sold under the brand name Viltepso, is a medication used for the treatment of Duchenne muscular dystrophy (DMD). Viltolarsen is a Morpholino antisense oligonucleotide. Any product involved in patent will be used for research purposes only.

pseudouridine-5′-Triphosphate

Nugene Biopharm Science providepseudouridine-5′-Triphosphate solution 100mM Sodium and 200mM Tris for RNA synthesis, mRNA synthesis, IVT.Packing size: 1mL, 10mL, 20mL, 100mL, 1L, etc.GMP management as per API manufacturing, approved Chinese FDA. Molecular Formula: C9H15N2O15P3Molecular Mass: 484.144 InChIInChI=N/A InChIKeyInChIKey=VEWJOCYCKIZKKV-GBNDHIKLSA-N Other Names for this Substance Bioactivity: MODERNA THERAPEUTICS INC – US2021/38529, 2021, A1

Adenosine 5′-triphosphate

Nugene Biopharm Science provide Adenosine 5′-triphosphate solution 100mM Sodium and 200mM Tris for RNA synthesis, mRNA synthesis, IVT.Packing size: 1mL, 10mL, 20mL, 100mL, 1L, etc.GMP management as per API manufacturing, approved Chinese FDA. Molecular Formula: C10H16N5O13P3Molecular Mass: 507.18 InChIInChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 InChIKeyInChIKey=ZKHQWZAMYRWXGA-KQYNXXCUSA-N SMILESO[C@H]1C@N=CN3)(OC@HO)(=O)O)(=O)O)[C@H]1O)[H] Canonical SMILESO=P(O)(O)OP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC=3C(=NC=NC32)N)C(O)C1O Other Names for this SubstanceAdenosine 5′-(tetrahydrogen triphosphate)Adenosine 5′-triphosphateAdenosine triphosphateAdenosine 5′-triphosphoric acidAtipi

Lanque Bio(Rnacure) signed a contract with Shanghai Baoshan District to build an mRNA clinical drug R&D and production base

Recently, Baoshan District, Shanghai, signed a contract with Lanque Biotechnology(Rnacure) to build an mRNA clinical drug R&D and GMP production base . Lanque Biology will plan and build a 5000 square meter R&D center and a 10,000 square meter GMP production base in Songnan Town and Luodian Town respectively, forming a spatial layout of “Southern …

Lanque Bio(Rnacure) signed a contract with Shanghai Baoshan District to build an mRNA clinical drug R&D and production base Read More »

Cordycepin

Cunningham et al. reported 3’-deoxyadenosine(Cordycepin) was first isolated from the culture filtrate of the medicinal fungus Cordyceps militaris in 1950.Herba Su has been identified as one of the important active ingredients of Cordyceps militaris.Cordycepin has a wide range of medical and health care values.Its medicine Physical activity includes anti-cancer, anti-metastasis, anti-tumor, anti-apoptosis, anti-inflammatory.Cordycepin can also …

Cordycepin Read More »

Lipid Nanoparticles for Therapeutic Delivery of GTI-2040

Mol Pharm . 2015 Jun 1;12(6):2010-8. doi: 10.1021/mp5008212. Epub 2015 Apr 28. D33-targeted lipid nanoparticles (aCD33LNs) were synthesized for delivery of GTI-2040, an antisense oligonucleotide (ASO) against the R2 subunit of ribonucleotide reductase, to acute myelogenous leukemia (AML). These LNs incorporated a deoxycholate-polyethylenimine (DOC-PEI) conjugate, which has shown significant activity to facilitate oligonucleotide delivery. Anti-CD33 scFv (aCD33) was …

Lipid Nanoparticles for Therapeutic Delivery of GTI-2040 Read More »

IVT mRNA is formulated into lipid nanoparticle vaccines using a cell-free production pipeline

author: Namit Chaudhary , Drew Weissman and Kathryn A. Whitehead Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the most rapid vaccine development in history, with mRNA vaccines at the forefront of those efforts.Although it is now clear that …

IVT mRNA is formulated into lipid nanoparticle vaccines using a cell-free production pipeline Read More »

A New Type of Labelling of Nucleosides and Nucleotides

A new labelling technique attaching fluorescein via a carbamoyl linker directly to the amino groups of the nucleobases was developed. The amino groups were first converted to the phenoxycarbonyl derivatives (10,15, 19, 58), which reacted under mild conditions with 5-aminofluorescein to give the corresponding N-[(fluorescein-5-ylamino)carbonyl] derivatives (11 ± 14, 16, 17, 20, 59, 60). The …

A New Type of Labelling of Nucleosides and Nucleotides Read More »